The Development of a Disease-Specific eCOA/ePRO: The Electronic Lupus Assessment Suite, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) April 14, 2020 -- Join Doug Pierce, President, Clinical Ink and Kyle Hogan, VP, Outcome Solutions, Clinical Ink in a live webinar on Thursday, April 30, 2020 at 1pm EDT (6pm BST/UK).
Only one drug specific for systemic lupus erythematosus (SLE) has been approved thus far. This is because for sponsors and CROs, recruiting the right patients and collecting quality data for lupus clinical trials are notoriously difficult. This webinar covers a new disease-specific application of Lumenis™ called eLAS. This is an integrative, powerful form of electronic clinical assessment (eCOA) that addresses the fundamental challenges of SLE research to accelerate the development of new treatments for this underserved group of patients.
This webinar will discuss the reasons why lupus research is so complex and how a comprehensive solution such as the eLAS platform can overcome the challenges of complex clinical trials when customized to address the idiosyncrasies of a specific therapeutic area, such as SLE, through features that:
• Eliminate conflicting data and duplicative entry requirements by presenting easy-to-understand data entry screens that walk users through pre-programmed workflows and study processes, give instructions, calculate data and provide training
• Minimize queries through real-time edit checks with pop-up data entry reminders so corrections can be made while the patient is still present
• Share data across the protocol-required questionnaires and visits, as well as formulate it into reports to make it immediately available to study team members through a web portal
• Allow clinicians to enter structured and non-structured data including numeric, text, VAS, audio, video and even handwritten notes for complete documentation
No matter how complex the trial type or protocol is, an eCOA application purpose-designed with the right functionality and services can vastly reduce site workload and improve site performance, data quality and the overall likelihood of successful study completion.
While this webinar focuses on lupus, this concept can be applied in any area and specific platforms for other areas, such as GI, CNS, dermatology, and others are in development.
For more information or to register for this event, visit The Development of a Disease-Specific eCOA/ePRO: The Electronic Lupus Assessment Suite.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Sydney Perelmutter, Xtalks, http://www.xtalks.com, +1 (416) 977-6555 x 352, [email protected]
Share this article